分级(工程)
肾透明细胞癌
肾细胞癌
医学
人工智能
肾癌
内科学
清除单元格
计算机科学
病理
肿瘤科
肿瘤分级
肾病科
肿瘤分期
梅德林
细胞
癌
作者
Jing Zhou,Bojin Su,Chang Zhao,QunXiong Huang,Na Cheng,JinMing Di,JianXiong Gu,Hailing Liu,Qiong Liang,DaYang Hui,ZiJin Weng,LuYing Tang,RiHong Yang,Lanqing Han,JianNing Chen,Yong Ren,Chunkui Shao
出处
期刊:iScience
[Cell Press]
日期:2026-06-01
卷期号:29 (6): 116182-116182
标识
DOI:10.1016/j.isci.2026.116182
摘要
The grading classification of clear cell renal cell carcinoma (CCRCC) is a crucial prognostic factor. However, manual observation can lead to subjective and inconsistent diagnoses. In this study, we aimed to develop a deep-learning-based grading system for CCRCC using whole-slide image (WSI) and to predict disease progression. A total of 305 CCRCC cases were used to develop the renal cell carcinoma artificial intelligence diagnosis (RCCAID) model for grading (188 training, 47 verification, and 70 testing cases) and the renal cell carcinoma artificial intelligence prognostic (RCCAIP) progression prediction model (288 cases). Progression was defined as the presence of distant and/or lymph node metastasis. Xception, ResNet50, and Inception V3 were employed. Model performance was assessed via confusion matrix, receiver operator characteristic curve (ROC) curve, and classification map. RCCAID achieved area under the curve (AUC) values of 0.987 (internal), 0.996 (in-house), and 0.967 (external). The quadratic weighted Cohen's kappa was 0.864, comparable to senior pathologists (0.871). RCCAIP achieved an AUC of 0.94 for progression prediction. Higher grades correlated with worse prognosis. RCCAID can accurately grade CCRCC in whole-slide images, and RCCAIP is effective in progression prediction, even for low-grade tumors.
科研通智能强力驱动
Strongly Powered by AbleSci AI